FindTrial
Sign In

Prospective Cohort Study on First-line Treatment Strategies and Prognostic Outcomes in Advanced Lung Cancer Patients Stratified by Molecular Profiling

Prospective Cohort Study on First-line Treatment Strategies and Prognostic Outcomes in Advanced Lung Cancer Patients Stratified by Molecular Profiling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106608
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-08-10
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

observation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Lung tumor confirmed by histopathology or cytopathology; 2. There are medical records and complete clinical information

Exclusion criteria

Exclusion criteria: 1.Suffering from malignant tumors of other systems; 2.Comorbid with severe underlying diseases.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Secondary

MeasureTime frame
Progression-Free Survival;Objective Response Rate;—

Countries

China

Contacts

Public ContactPanwen Tian

West China Hospital of Sichuan University

mrascend@163.com+86 181 0805 5032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026